In an interview last year with online US health publication Stat, the German financier and lifelong teetotaller Christian Angermayer described the single most meaningful experience in his life. Five years previously, at the age of 35, he travelled with friends to a country where psychedelic drugs are legal and had his first trip. It was, for him, utterly transformative. “Nothing has ever come close to it,” he said.  As an entrepreneur, Angermayer soon began investigating the business potential of developing psychoactive drugs into approved medications. Psilocybin, found in magic mushrooms, is currently being researched for its potential benefits to patients…

Want to continue reading?

Introductory offer: Sign up today and pay €200 for an annual membership, a saving of €100.

Subscribe

Cancel anytime.

Are you already a member? .